Article Name Medtech
Expands to 715 clinics across 26 cities as the company reinforces its focus on standardised clinical care, technology-led operations, and patient-first dentistry
24th February, 2026
Minnix will be responsible for leading the Law Group and Public Affairs at BD
23rd February, 2026
Image-guided biopsies enhance diagnostic accuracy by a significant margin to 90-95 per cent
20th February, 2026
As QMSR, EUDAMED, cybersecurity, and AI controls widen the compliance surface, leading manufacturers are converting the same pressures into measurable gains in quality, delivery, cost, and speed through digitally fluent teams, auditable AI, resilient supply networks, and data centric regulatory operations.
19th February, 2026
These new customer engagements underscore the adoption of Positron’s next-generation PET-CT technology and comprehensive services solution
18th February, 2026
Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimisation, Aligning with IM8 Growth Strategy
18th February, 2026
The patient recovered well and was discharged in stable condition
16th February, 2026
Huber is a seasoned sales and commercial executive with more than two decades of leadership experience in healthcare and medical device sales
13th February, 2026
Next-generation variable-rate contrast management system designed to advance precision, safety, and efficiency in image-guided cardiovascular procedures
12th February, 2026
NexTech Summit 2026 delivered a purpose-built platform for India’s most influential technology leaders to engage in candid, peer-driven conversations on the realities of scaling AI, strengthening cyber resilience, modernising enterprise platforms, and aligning technology with boardroom priorities
12th February, 2026
Cervco's Gut-Brain Wellness Test helps adults monitor bacteria and lifestyle factors that research links to cognitive wellness—no doctor's prescription required
11th February, 2026
Despite such a revolution, routine screening continues to be the largest cancer treatment opportunity lost in India
09th February, 2026
The approval was based on results from the Asian multicenter Phase 3 ENLIGHT UC study (ES101002) and the global ELEVATE UC Phase 3 program (ELEVATE UC 52 and ELEVATE UC 12)
09th February, 2026
Physician-Led, Cash-Pay Platform Combines Two High-Volume Practices to Expand Access to Evidence-Based Men’s Health Care
06th February, 2026
BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing a Phase 1 clinical study, showing promising early clinical results
06th February, 2026
Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health
05th February, 2026
Reinforcing its commitment to accessible, expert-led cancer care across India
05th February, 2026
Larkin joins Belmont with over three decades of leadership across medical technology and patient care sectors
04th February, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer